Direct listing Announced
Conexeu Sciences direct listing
Announced 11 May 2026 · NASDAQ: CNXU
Advisers
Lead managers
Not disclosed
- Issuer
- Conexeu Sciences
- Issuer based in
- United States
- Sector
- Life Sciences
Similar deals
- Neurizon Therapeutics placement Nov 2026 · US$3m · Healthcare
- Invex Therapeutics placement Oct 2026 · US$7m · Healthcare
- Identifai Genetics IPO Oct 2026 · US$7m · Healthcare
- Cynata Therapeutics entitlement offer Oct 2026 · US$641,319 · Healthcare
- Nyrada placement Sep 2026 · US$10m · Healthcare
Sources
- 11 May 2026 Final IPO prospectus (424B4), Conexeu Sciences Inc. sec.gov
